πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Orchestra BioMed Holdings, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CVRx, Inc.

CVRx, Inc. logo
Market Cap: Low
Employees: Low

Barostim

CVRx, Inc. is a commercial-stage medical device company focusing on developing, manufacturing, and commercializing neuromodulation solutions for cardiovascular diseases, offering Barostim for heart failure patients.

Tags: Barostim, cardiovascular, heart failure, medical device, neuromodulation

Symbol: CVRX

Recent Price: $12.77

Industry: Medical - Devices

CEO: Mr. Kevin Hykes

Sector: Healthcare

Employees: 200

Address: 9201 West Broadway Avenue, Minneapolis, MN 55445

Phone: 763 416 2840

Last updated: 2024-12-31

Nemaura Medical Inc.

Nemaura Medical Inc. logo
Market Cap: Lowest
Employees: Lowest

sugar BEAT

Nemaura Medical Inc. is a medical technology company that develops and commercializes diagnostic medical devices, including a non-invasive continuous glucose monitoring device for diabetes management.

Tags: continuous glucose monitoring, diabetes, diagnostic devices, medical technology, wellness

Symbol: NMRD

Recent Price: $0.00

Industry: Medical - Devices

CEO: Dr. Dewan Fazlul Hoque Chowdhury Ph.D.

Sector: Healthcare

Employees: 36

Address: 57 West 57th Street, New York, NY 10019

Phone: 646 416 7912

Last updated: 2024-12-31

Microbot Medical Inc.

Microbot Medical Inc. logo
Market Cap: Lowest
Employees: Lowest

Vi Rob, Tip CAT, Cardio Sert, and Liberty micro-robotic technologies

Microbot Medical Inc. is a pre-clinical medical device company focusing on the research, design, and development of robotic endoluminal surgery devices for minimally invasive surgery. The company collaborates with Stryker Corporation and owns patents worldwide.

Tags: medical device, minimally invasive, patents, robotic surgery, strategic collaboration, technology development

Symbol: MBOT

Recent Price: $1.18

Industry: Medical - Instruments & Supplies

CEO: Mr. Harel Gadot

Sector: Healthcare

Employees: 21

Address: 25 Recreation Park Drive, Hingham, MA 02043

Phone: 781 875 3605

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

HeartBeam, Inc.

HeartBeam, Inc. logo
Market Cap: Lowest
Employees: Lowest

Heart Beam AIMIGoβ„’

Heart Beam, Inc. is a medical technology company focused on telemedicine solutions for the detection and monitoring of cardiac disease. It offers a credit card-sized ECG device and a cloud-based diagnostic software system for remote patient monitoring.

Tags: ECG, cardiac monitoring, healthcare technology, remote patient monitoring, telemedicine

Symbol: BEAT

Recent Price: $2.16

Industry: Medical - Healthcare Information Services

CEO: Mr. Robert P. Eno

Sector: Healthcare

Employees: 15

Address: 2118 Walsh Avenue, Santa Clara, CA 95050

Phone: 408 899 4443

Last updated: 2024-12-31

bluebird bio, Inc.

bluebird bio, Inc. logo
Market Cap: Low
Employees: Medium

betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel

bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

Tags: betibeglogene autotemcel, biotechnology, elivaldogene autotemcel, gene therapy, genetic diseases, lovotibeglogene autotemcel

Symbol: BLUE

Recent Price: $7.86

Industry: Biotechnology

CEO: Mr. Andrew Obenshain

Sector: Healthcare

Employees: 375

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Leadership

  • Sarah Alspach, Senior Vice President, External Affairs
  • Rich Colvin, MD, PhD, Chief Medical Officer
  • Kasra Kasraian, Senior Vice President, Technical Development and Operations
  • Tom Klima, Chief Commercial & Operating Officer
  • Andrew Obenshain, Chief Executive Officer
  • Scott Shoemaker, Senior Vice President, Quality
  • James Sterling, Chief Financial Officer
  • Joe Vittiglio, Chief Business and Legal Officer
  • Andrea Walton, Chief People Officer
  • Leslie Wilder, Vice President, Head of Regulatory Science
  • Mark Vachon, Chairman; Formerly of GE
  • John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
  • Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
  • Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
  • Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
  • Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
  • Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
  • Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare

Last updated: 2024-12-31

Cabaletta Bio, Inc.

Cabaletta Bio, Inc. logo
Market Cap: Low
Employees: Low

DSG3-CAART

Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies for B cell-mediated autoimmune diseases. Its leading product, DSG3-CAART, is in Phase I trials for treating mucosal pemphigus vulgaris.

Tags: CAAR T cells, T cell therapies, autoimmune diseases, biotechnology, clinical trials

Symbol: CABA

Recent Price: $2.24

Industry: Biotechnology

CEO: Dr. Steven A. Nichtberger M.D.

Sector: Healthcare

Employees: 136

Address: 2929 Arch Street, Philadelphia, PA 19104

Phone: 267 759 3100

Leadership

  • Steven Nichtberger, M.D., President, Chief Executive Officer, and Co-Founder
  • Samik Basu, M.D., Chief Scientific Officer
  • Gwendolyn Binder, Ph.D., President, Science & Technology
  • David J. Chang, M.D., M.P.H, FACR, Chief Medical Officer
  • Arun Das, M.D., Chief Business Officer
  • Michael Gerard, General Counsel
  • Heather Harte-Hall, Chief Compliance Officer
  • Anup Marda, Chief Financial Officer
  • Martha O’Connor, Chief Human Resources Officer
  • Sarah Yuan, Ph.D., Chief Technology Officer
  • Catherine Bollard, M.D., Independent Director, George Washington University
  • Scott Brun, M.D., Independent Director, formerly at AbbVie
  • Richard Henriques, M.B.A., Independent Director, former CFO of Gates Foundation, former Controller at Merck
  • Mark Simon, M.B.A., Independent Director, Torreya Partners
  • Shawn Tomasello, M.B.A., Independent Director, former CCO of Kite Pharma, Inc.

Last updated: 2024-12-31

MediciNova, Inc.

MediciNova, Inc. logo
Market Cap: Low
Employees: Lowest

MN-166 (ibudilast)

Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.

Tags: United States, biopharmaceutical, fibrotic diseases, neurological disorders, novel therapeutics, solid tumors, unmet medical needs

Symbol: MNOV

Recent Price: $2.11

Industry: Biotechnology

CEO: Dr. Yuichi Iwaki M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 4275 Executive Square, La Jolla, CA 92037

Phone: 858 373 1500

Leadership

  • Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
  • Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
  • David H. Crean, Ph.D., Chief Business Officer
  • Jason J. Kruger, CPA (inactive), Chief Financial Officer
  • Hideki Nagao, Member of the Board of Directors
  • Carolyn Beaver, Member of the Board of Directors
  • Nicole Lemerond, CFA, Member of the Board of Directors

Last updated: 2024-12-31

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANA001

A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.

Tags: biotechnology, cardiometabolic diseases, clinical trials, infectious diseases, neurodegenerative diseases

Symbol: NRBO

Recent Price: $2.36

Industry: Biotechnology

CEO: Mr. Hyung-Heon Kim

Sector: Healthcare

Employees: 8

Address: 200 Berkeley Street, Boston, MA 02116

Phone: 857 702 9600

Last updated: 2024-12-31

enVVeno Medical Corporation

enVVeno Medical Corporation logo
Market Cap: Lowest
Employees: Lowest

Veno Valve

en VVeno Medical Corporation is a medical device company focused on the development of bioprosthetic tissue-based solutions to treat venous diseases. Its lead product, the Veno Valve, is designed to treat severe deep venous chronic venous insufficiency.

Tags: Veno Valve, bioprosthetic solution, chronic venous insufficiency, medical device, venous diseases

Symbol: NVNO

Recent Price: $3.03

Industry: Medical - Devices

CEO: Mr. Robert A. Berman

Sector: Healthcare

Employees: 31

Address: 70 Doppler, Irvine, CA 92618

Phone: 949 261 2900

Last updated: 2024-12-31

Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. logo
Market Cap: Low
Employees: Lowest

Back Beat Cardiac Neuromodulation Therapy (CNT), Virtue Sirolimus Angio Infusion Balloon (SAB)

Orchestra Bio Med Holdings, Inc. is a biomedical innovation company specializing in treatments for hypertension and atherosclerotic artery disease, with strategic collaborations with Medtronic and Terumo Corporation.

Tags: atherosclerotic artery disease, biomedical, hypertension, innovation, minimally invasive surgery, strategic partnership

Symbol: OBIO

Recent Price: $4.25

Industry: Biotechnology

CEO: Mr. David P. Hochman

Sector: Healthcare

Employees: 56

Address: 150 Union Square Drive, New Hope, PA 18938

Phone: 215 862 5797

Last updated: 2024-12-31

Organovo Holdings, Inc.

Organovo Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Novo Gen Bioprinters

Organovo Holdings, Inc. is a biotechnology company that develops 3D tissues to model human diseases, utilizing proprietary bioprinting technologies such as Novo Gen Bioprinters for fabricating living tissues.

Tags: 3D tissues, Ex Vive, Novo Gen Bioprinters, bioprinting, biotechnology, human disease

Symbol: ONVO

Recent Price: $0.36

Industry: Biotechnology

CEO: Mr. Keith E. Murphy

Sector: Healthcare

Employees: 20

Address: 11555 Sorrento Valley Road, Solana Beach, CA 92121

Phone: 858 224 1000

Leadership

  • Keith Murphy, Executive Chairman, CEO
  • Thomas P. Hess, Chief Financial Officer
  • Curtis Tyree, Ph.D., Senior Vice President, Strategy and Business Development
  • Adam K. Stern, CEO
  • Alison Milhous, Vice President, Accounting
  • David Gobel, CEO
  • Doug Cohen, President and Chief Executive Officer
  • Vaidehi Joshi, Director of Discovery Biology

Last updated: 2024-12-31

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SAB-185, SAB-176

SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.

Tags: COVID-19, autoimmune disorders, biopharmaceutical, cancer, human antibodies, immunotherapy, influenza

Symbol: SABS

Recent Price: $4.15

Industry: Biotechnology

CEO: Mr. Samuel J. Reich

Sector: Healthcare

Employees: 57

Address: 2100 East 54th Street North, Sioux Falls, SD 57104

Phone: 605 679 6980

Last updated: 2024-12-31

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

SON-1010, SON-080

Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.

Tags: albumin binding technology, biologic medicines, biotechnology, interleukin 12, interleukin 6, oncology

Symbol: SONN

Recent Price: $1.48

Industry: Biotechnology

CEO: Dr. Pankaj Mohan Ph.D.

Sector: Healthcare

Employees: 12

Address: 100 Overlook Center, Princeton, NJ 08540

Phone: 609-375-2227

Leadership

  • Pankaj Mohan, Ph.D., Founder, CEO & Chairman
  • Jay Cross, Chief Financial Officer
  • John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
  • Susan Dexter, Chief Technical Officer
  • Richard Kenney, M.D., Chief Medical Officer
  • Albert Dyrness, Board Member
  • Nailesh Bhatt, Chief Executive Officer & Board Member
  • Raghu Rao, Board Member
  • Donald Griffith, Financial Controller
  • Lori McNeill, Board Member

Last updated: 2024-12-31

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Medium

G-MAB antibody library, Sofusa drug delivery technology, ZTlido

Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.

Tags: CAR-T therapy, antibody library, autoimmune diseases, biopharmaceutical, cancer therapy, drug delivery

Symbol: SRNE

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Henry H. Ji Ph.D.

Sector: Healthcare

Employees: 949

Address: 4955 Directors Place, San Diego, CA 92121

Phone: 858 203 4100

Last updated: 2024-12-31

Verve Therapeutics, Inc.

Verve Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

VERVE-101

Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.

Tags: VERVE-101, biotechnology, cardiovascular diseases, gene editing, genetic medicines

Symbol: VERV

Recent Price: $5.54

Industry: Biotechnology

CEO: Dr. Sekar Kathiresan M.D.

Sector: Healthcare

Employees: 255

Address: 500 Technology Square, Cambridge, MA 02139

Phone: 617 603 0070

Leadership

  • Andrew Ashe, President, Chief Operating Officer and General Counsel
  • Victoria Bartlett, Vice President, Program and Alliance Management
  • Dan Balian, Associate Director, Supply Chain Management
  • Allen Barrett, Director, Corporate Counsel

Last updated: 2024-12-31

Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd. logo
Market Cap: High
Employees: Low

NURTEC ODT (rimegepant)

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops product candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States.

Tags: biopharmaceutical, migraine treatment, neurological diseases, neuropsychiatric disorders, rare disorders

Symbol: BHVN

Recent Price: $35.78

Industry: Biotechnology

CEO: Dr. Vladimir Coric M.D.

Sector: Healthcare

Employees: 239

Address: 215 Church Street, New Haven, CT 06510

Phone: 203 404 0410

Last updated: 2024-12-31

Boston Scientific Corporation

Boston Scientific Corporation logo
Market Cap: Highest
Employees: Highest

Medical Devices

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide, covering segments like Med Surg, Rhythm and Neuro, and Cardiovascular.

Tags: Cardiovascular, Gastrointestinal, Healthcare, Interventional Specialties, Medical Devices, Neuro, Pulmonary

Symbol: BSX

Recent Price: $89.68

Industry: Medical - Devices

CEO: Mr. Michael F. Mahoney

Sector: Healthcare

Employees: 48000

Address: 300 Boston Scientific Way, Marlborough, MA 01752-1234

Phone: 508 683 4000

Last updated: 2024-12-31

BioCardia, Inc.

BioCardia, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cardi AMP Cell Therapy System

Bio Cardia, Inc. is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Their lead candidate, the Cardi AMP Cell Therapy System, targets heart failure and myocardial ischemia, with additional developments in cell delivery and therapeutic platforms.

Tags: cardiovascular, cell therapy, clinical-stage, pulmonary diseases, regenerative medicine

Symbol: BCDA

Recent Price: $2.15

Industry: Biotechnology

CEO: Dr. Peter A. Altman Ph.D.

Sector: Healthcare

Employees: 16

Address: 320 Soquel Way, Sunnyvale, CA 94085

Phone: 650 226 0120

Leadership

  • David McClung, CFO
  • Edward Gillis, Sr. VP of Devices
  • Debby Holmes-Higgin, MPH, VP of Clinical
  • Andrew Scott Blank, Chairman
  • Simon H. Stertzer, M.D., Professor of Medicine, Emeritus
  • Jay M. Moyes, Director
  • Bill Facteau, President and Chief Executive Officer
  • Richard Krasno, Ph.D., Director
  • Jim Allen, Chief Executive Officer and President
  • Peter Altman, Ph.D., President and Chief Executive Officer

Last updated: 2024-12-31

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Imm Celz

Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.

Tags: biotechnology, immunology, neurology, orthopedics, stem cell treatments, urology

Symbol: CELZ

Recent Price: $2.34

Industry: Biotechnology

CEO: Mr. Timothy Warbington

Sector: Healthcare

Employees: 4

Address: 211 East Osborn Road, Phoenix, AZ 85012

Phone: 480 399 2822

Last updated: 2024-12-31